NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (“Pliant” or the “Company”) (NASDAQ: PLRX). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of NAPCO Security Technologies, Inc (“NAPCO” or the “Company”) (NASDAQ: NSSC). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, Nov. 25, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Bancorp, Inc. (“Bancorp” or the “Company”) (NASDAQ: TBBK). Such investors are advised to contact Danielle Peyton at [email protected] or […]
NEW YORK, Nov. 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. […]